Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117741618 | 11774161 | 8 | F | 20151007 | 20160909 | 20151124 | 20160919 | EXP | US-PFIZER INC-2015391798 | PFIZER | 18.00 | YR | M | Y | 109.00000 | KG | 20160919 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117741618 | 11774161 | 1 | PS | CRIZOTINIB | CRIZOTINIB | 1 | Oral | 250 MG, CYCLIC (2X/DAY) ON DAY 1-21 (COURSE A, B) | 7250 | MG | Y | 202570 | 250 | MG | |||||
| 117741618 | 11774161 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | Intrathecal | UNK, CYCLIC (ON DAY 1, PRO-PHASE) | 1400 | MG | 72168 | SOLUTION FOR INJECTION | |||||||
| 117741618 | 11774161 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | UNK, CYCLIC, OVER 1-30 MINUTES EVERY 12 HOURS ON DAYS 4, 5 (COURSE A) | 1400 | MG | 72168 | SOLUTION FOR INJECTION | |||||||
| 117741618 | 11774161 | 4 | SS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK, CYCLIC, ON DAYS 4 AND 5 (COURSE B) | 120 | MG | 50467 | ||||||||
| 117741618 | 11774161 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | UNK, CYCLIC (ON DAY 1 PRO-PHASE) | 7080 | MG | 11719 | ||||||||
| 117741618 | 11774161 | 6 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intravenous (not otherwise specified) | UNK, CYCLIC, OVER 3 HOURS (COURSE A, B) | 7080 | MG | 11719 | ||||||||
| 117741618 | 11774161 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | UNK, CYCLIC, (PROPHASE, COURSE B) | 2350 | MG | 0 | ||||||||
| 117741618 | 11774161 | 8 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | UNK, CYCLIC (PROPHASE, COURSE A, B) | 120 | MG | 0 | ||||||||
| 117741618 | 11774161 | 9 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | UNK, CYCLIC, OVER 60 MIN ON DAY 1-5 (COURSE A) | 9350 | MG | 0 | ||||||||
| 117741618 | 11774161 | 10 | C | HYDROCORTISONE ACETATE. | HYDROCORTISONE ACETATE | 1 | Intrathecal | 7.5-12MG, ON DAY 1 (PROPHASE) | 0 | ||||||||||
| 117741618 | 11774161 | 11 | C | VP-16 | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 100 MG/M2, CYCLIC, ON DAYS 4 AND 5 (COURSE A) | 0 | 100 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117741618 | 11774161 | 1 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 2 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 4 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 5 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 7 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 8 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 9 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 10 | Anaplastic large cell lymphoma T- and null-cell types |
| 117741618 | 11774161 | 11 | Anaplastic large cell lymphoma T- and null-cell types |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117741618 | 11774161 | OT |
| 117741618 | 11774161 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117741618 | 11774161 | Enterocolitis | |
| 117741618 | 11774161 | Hypokalaemia | |
| 117741618 | 11774161 | Lung infection | |
| 117741618 | 11774161 | Nausea | |
| 117741618 | 11774161 | Pleural effusion | |
| 117741618 | 11774161 | Stomatitis | |
| 117741618 | 11774161 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117741618 | 11774161 | 1 | 20150908 | 20151013 | 0 | |
| 117741618 | 11774161 | 2 | 20150903 | 0 | ||
| 117741618 | 11774161 | 3 | 20150911 | 0 | ||
| 117741618 | 11774161 | 4 | 20151002 | 0 | ||
| 117741618 | 11774161 | 5 | 20150903 | 0 | ||
| 117741618 | 11774161 | 7 | 20150903 | 0 | ||
| 117741618 | 11774161 | 8 | 20150903 | 0 | ||
| 117741618 | 11774161 | 9 | 20150908 | 0 | ||
| 117741618 | 11774161 | 10 | 20150903 | 20150903 | 0 | |
| 117741618 | 11774161 | 11 | 20150911 | 20150912 | 0 |